Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Nov;93(11):1089-94.
doi: 10.1177/0022034514529974. Epub 2014 Aug 19.

Antibacterial efficacy of exogenous nitric oxide on periodontal pathogens

Affiliations
Comparative Study

Antibacterial efficacy of exogenous nitric oxide on periodontal pathogens

C J Backlund et al. J Dent Res. 2014 Nov.

Abstract

Current treatments for periodontitis (e.g., scaling/root planing and chlorhexidine) have limited efficacy since they fail to suppress microbial biofilms satisfactorily over time, and the use of adjunctive antimicrobials can promote the emergence of antibiotic-resistant organisms. Herein, we report the novel application of nitric oxide (NO)-releasing scaffolds (i.e., dendrimers and silica particles) as anti-periodontopathogenic agents. The effectiveness of macromolecular NO release was demonstrated by a 3-log reduction in periodontopathogenic Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis viability. In contrast, Streptococcus mutans and Streptococcus sanguinis, caries-associated organisms, were substantially less sensitive to NO treatment. Both dendrimer- and silica-based NO release exhibited substantially less toxicity to human gingival fibroblasts at concentrations necessary to eradicate periodontopathogens than did clinical concentrations of chlorhexidine. These results suggest the potential utility of macromolecular NO-release scaffolds as a novel platform for the development of periodontal disease therapeutics.

Keywords: Aggregatibacter actinomycetemcomitans; Porphyromonas gingivalis; dendrimers; periodontal diseases; periodontitis; silica.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Bactericidal efficacy of (A) 70 mol% MAP3 particles, (B) G1-PAMAM-PO dendrimers, and (C) proline against A. actinomycetemcomitans in Tris-PBS after 2 hr. Bactericidal efficacy of (D) 70 mol% MAP3 particles, (E) G1-PAMAM-PO dendrimers, and (F) proline against P. gingivalis in Tris-PBS after 2 hr. NO-releasing material denoted by rectangles (-■-) and non-NO-releasing controls denoted by circles (-•-). Error bars signify standard deviation of the mean viability (CFU/mL). For all measurements, n = 3 or more pooled experiments.
Figure 2.
Figure 2.
Bactericidal efficacy of (A) 70 mol% MAP3 particles, (B) G1-PAMAM-PO dendrimers, and (C) proline against S. mutans in Tris-PBS after 2 hr. Bactericidal efficacy of (D) 70 mol% MAP3 particles, (E) G1-PAMAM-PO dendrimers, and (F) proline against S. sanguinis in Tris-PBS after 2 hr. NO-releasing material denoted by rectangles (-■-) and non-NO-releasing controls denoted by circles (-•-). Error bars signify standard deviation of the mean viability (CFU/mL). For all measurements, n = 3 or more pooled experiments.
Figure 3.
Figure 3.
Cytotoxicity of NO-releasing materials and non-NO-releasing controls at minimum bactericidal concentration (MBC) two-hour concentrations (or maximum concentration tested). Viability measured as metabolically active fibroblasts with MTS and presented as normalized percentage relative to untreated cells. Chlorhexidine toxicity shown for clinical doses [0.12 and 0.20% (w/w)]. Of note, the numbers after the materials (e.g., 2, 4, 48, and 64) correspond to the MBC data (in mg/mL). Error bars represent standard deviation of the mean. For all values, n = 4 or more replicate measurements.

References

    1. Allaker RP, Silva Mendez LS, Hardie JM, Benjamin N. (2001). Antimicrobial effect of acidified nitrite on periodontal bacteria. Oral Microbiol Immunol 16:253-256. - PubMed
    1. Carossa S, Pera P, Doglio P, Lombardo S, Colagrande P, Brussino L, et al. (2001). Oral nitric oxide during plaque deposition. Eur J Clin Invest 31:876-879. - PubMed
    1. Carpenter AW, Schoenfisch MH. (2012). Nitric oxide release: Part II. Therapeutic applications. Chem Soc Rev 41:3742-3752. - PMC - PubMed
    1. Charbonneau DL, Snider AG. (1997). Reduced chlorhexidine tooth stain coverage by sequential administration of monoperoxyphthalic acid in the beagle dog. J Dent Res 76:1596-1601. - PubMed
    1. Choudhury T, Sato EF, Inoue M. (2007). Nitrite reductase in Streptococcus mutans plays a critical role in the survival of this pathogen in oral cavity. Oral Microbiol Immunol 22:384-389. - PubMed

Publication types

MeSH terms